follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsStéphanie Bédard-Châteauneuf

      Articles by Stéphanie Bédard-Châteauneuf

      Automotive

      US Tax Credit Could Rev Up Electric Vehicle Production In Canada

      Aug 4 Stéphanie Bédard-Châteauneuf
      Canadian car makers breathed a sigh of relief last week when US lawmakers decided to scrap part of a large incentive package for electric vehicles (EVs) that originally excluded EVs assembled in Canada from a ... [Read]
      Alternative Energy

      Tech Giants Commit Nearly $1 Billion Toward Carbon Capture

      Apr 28 Stéphanie Bédard-Châteauneuf
      Some of the world’s largest companies are teaming up to commit nearly $1 billion in spurring the carbon-capture market. On April 12, Stripe, Facebook, Alphabet, Shopify and McKinsey & Co. Inc. announced the creation of ... [Read]
      Editorspicks

      Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030

      Apr 21 Stéphanie Bédard-Châteauneuf
      Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance infections. If solutions aren’t found and put in place, 10 million people could die from antibiotic resistance-related diseases by ... [Read]
      Health

      Why Psychedelics Could Soon Replace Antidepressants

      Apr 13 Stéphanie Bédard-Châteauneuf
      Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety medications available, treatment resistance occurs in roughly 30% of patients. Anxiety ... [Read]
      Blockchain

      The World’s Largest Asset Manager Is About to Enter Crypto Space

      Feb 24 Stéphanie Bédard-Châteauneuf
      BlackRock, the world’s largest asset manager with $10 trillion in assets under management for institutions, is about to enter the crypto space. The New York-based company will soon allow its customers to trade crypto through ... [Read]
      Gold

      Silver Could Outperform Gold in 2022

      Jan 20 Stéphanie Bédard-Châteauneuf
      After a year of underperformance, investors may turn to silver again this year. Silver’s price action has suffered in 2021 in part due to supply bottlenecks and significantly rising energy costs. Industrial silver will contribute ... [Read]

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2025 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2025 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE EV Technology Group Email Alerts
      Get FREE EV Technology Group Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x